Invention Grant
- Patent Title: Treatment of type 1 diabetes
- Patent Title (中): 1型糖尿病的治疗
-
Application No.: US13703147Application Date: 2011-06-09
-
Publication No.: US09271984B2Publication Date: 2016-03-01
- Inventor: Pascale Fouqueray , Daniel Cravo , Sophie Hallakou-Bozec , Sébastien Bolze
- Applicant: Pascale Fouqueray , Daniel Cravo , Sophie Hallakou-Bozec , Sébastien Bolze
- Applicant Address: FR Lyon
- Assignee: POXEL
- Current Assignee: POXEL
- Current Assignee Address: FR Lyon
- Agency: Nixon & Vanderhye P.C.
- Priority: EP10305611 20100609
- International Application: PCT/EP2011/059589 WO 20110609
- International Announcement: WO2011/154496 WO 20111215
- Main IPC: A01N43/66
- IPC: A01N43/66 ; A61K31/53 ; A61K9/20
Abstract:
The present invention relates to triazine derivatives of formula (I) for their use in the treatment of type 1 diabetes mellitus, and to compositions comprising said triazine derivatives.
Public/Granted literature
- US20130131066A1 TREATMENT OF TYPE 1 DIABETES Public/Granted day:2013-05-23
Information query
IPC分类:
